Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lespedeza buergeri

ABSTRACT: Lespedeza buergeri Genome sequencing and assembly

PROVIDER: PRJNA797562 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17633451_1.fastq.gz	Fastqsanger.gz
	SRR17633451_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Lespedeza cuneata

Project description:Lespedeza cuneata Genome sequencing and assembly

| PRJNA995375 | ENA

High-throughout sequencing of triple negative breast cancer cells treated with Lespedeza bicolor root

Project description:The high-throughput sequencing technology was performed after the treatment of human triple negative breast cancer cells MDA-MB-231 and BT549 with Lespedeza bicolor root extracted by ourselves, to explore the expression of genes related to cell proliferation, adhesion, migration and invasion of human triple negative breast cancer cells MDA-MB-231 and BT549 after the treatment of Lespedeza bicolor root changes, and to find an interesting target gene.

2024-03-27 | GSE262226 | GEO

Lespedeza bicolor

Project description:Lespedeza bicolor overview

| PRJNA624690 | ENA

Lespedeza cuneata

Project description:Lespedeza cuneata overview

| PRJNA1059729 | ENA

Lespedeza buergeri

Project description:Lespedeza buergeri overview

| PRJNA815443 | ENA

Lespedeza maritima

Project description:Lespedeza maritima Organism overview

| PRJNA290159 | ENA

Lespedeza bicolor

Project description:Leaf Transcriptome of Lespedeza bicolor

| PRJNA428830 | ENA

Lespedeza maritima

Project description:Lespedeza maritima Raw sequence reads

| PRJNA290063 | ENA

High-throughout sequencing of triple negative breast cancer cells treated with Lespedeza bicolor root

Project description:High-throughout sequencing of triple negative breast cancer cells treated with Lespedeza bicolor root

| PRJNA1090846 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data